Podrobno

Adaptive immune cell reactivity to polycaprolactone, alginate, chitosan, and zein nanofibers
ID Zidar, Anže (Avtor), ID Zupančič, Špela (Avtor), ID Gobec, Martina (Avtor), ID Kristl, Julijana (Avtor), ID Jeras, Matjaž (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (4,19 MB)
MD5: 12A34369BA56386BC5E5D3A44C911DA9
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S014181302508119X Povezava se odpre v novem oknu

Izvleček
This study explores how nanofiber chemical composition influences human immune cell responses, a key factor in the body's defense against foreign substances. Nanofiber mats composed of polycaprolactone (PCL), alginate (ALG), chitosan (CS), and zein were incubated with both unstimulated and phytohemagglutinin-L-stimulated peripheral blood mononuclear cells (PBMCs), as well as immature and mature monocyte-derived dendritic cells (MoDCs). We evaluated viability, metabolic activity, and cytokine release of PBMCs while in MoDCs, we assessed surface marker expression, phagocytic capacity, and allogeneic T-cell stimulatory function of MoDCs. Results demonstrate that nanofiber composition significantly influenced immune cell responses. While PCL and ALG nanofibers showed no significant effects on PBMCs, those made of CS, reduced their metabolic activity, warranting caution in their use. In contrast, zein nanofibers increased both metabolic activity and pro-inflammatory cytokine release of PBMCs, suggesting their potential immunogenicity. In MoDCs, PCL and CS nanofibers impaired both their phenotypic maturation and functional performance, including antigen uptake and presentation. Zein nanofibers induced changes in MoDC surface marker expression, however their overall functionality remained intact. In contrast, ALG nanofibers exhibited the highest biocompatibility, with minimal impact on both immature and mature MoDCs. This favorable profile of ALG nanofibers supports their suitability for biomedical applications, such as tissue engineering and drug delivery. Overall, our findings underscore the importance of thorough immunological safety assessment of nanofiber-based biomaterials prior to their clinical use.

Jezik:Angleški jezik
Ključne besede:polymers, dendritic cells, PBMCs, immunity, safety, chemical composition, nanofibers
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:10 str.
Številčenje:Vol. 328, pt. 2, [article no.] 147562
PID:20.500.12556/RUL-175850 Povezava se odpre v novem oknu
UDK:66.017-022.513.2616-097
ISSN pri članku:0141-8130
DOI:10.1016/j.ijbiomac.2025.147562 Povezava se odpre v novem oknu
COBISS.SI-ID:250776067 Povezava se odpre v novem oknu
Datum objave v RUL:11.11.2025
Število ogledov:87
Število prenosov:17
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:International journal of biological macromolecules
Skrajšan naslov:Int. j. biol. macromol.
Založnik:Butterworth Scientific Ltd, Elsevier
ISSN:0141-8130
COBISS.SI-ID:25637888 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:polimeri, dendritične celice, PBMC, imunost, varnost, kemijska sestava, nanovlakna, imunski odziv

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0189
Naslov:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J7-4418
Naslov:Nanovlakna za sočasno dostavo koktajlov izbrane mikrobiote in protimikrobnih učinkovin za lokalno zdravljenje vaginalnih infekcij

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Univerza v Ljubljani
Številka projekta:SN-ZRD/22-27/0510
Naslov:Kvantne tehnologije za transport in komunikacije v 21. stoletju
Akronim:KTTK21

Financer:EC - European Commission
Številka projekta:C333-19-952061
Naslov:European Regional Development Fund
Akronim:EATRIS-TRI.si

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj